Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.

1. We have investigated the correlation between relaxation and changes in cyclic nucleotide content of human tracheal smooth muscle (HTSM) in vitro following inhibitory non‐adrenergic non‐cholinergic (i‐NANC) neural bronchodilator responses evoked by electrical field stimulation (EFS), and compared these with changes seen with sodium nitroprusside (SNP), 3‐morpholinosydnonimine (SIN‐1) and vasoactive intestinal peptide (VIP). The effects of N omega‐nitro‐L‐arginine methyl ester (L‐NAME), Methylene Blue and alpha‐chymotrypsin (alpha‐CT) were studied. 2. EFS (10 Hz, 1 ms, 40 V for 30 s) evoked a time‐dependent relaxation accompanied by a concurrent rise in cGMP, both of which were maximal at 30 s and unaffected by epithelium removal. Levels of cAMP were more variable than those of cGMP and were not significantly changed at any time point. 3. SIN‐1 (1 mM) and SNP (100 microM) also produced time‐dependent relaxations which were maximal between 2 and 8 min, accompanied by concomitant rises in cGMP; however, these changes were larger than those associated with i‐NANC relaxations. cAMP levels were unchanged at all time points. 4. EFS‐evoked i‐NANC relaxations and cGMP increases (time, t = 30 s) were inhibited by L‐NAME. The effects were partially reversed by L‐arginine (1 mM), but not by D‐arginine. D‐NAME and alpha‐CT (2 u ml‐1) had no effect on either relaxation or cGMP accumulation. Tetrodotoxin (TTX, 3 microM) inhibited both relaxation and cGMP accumulation. 5. VIP (1 microM) also produced a time‐dependent relaxation associated with a concurrent rise in cAMP levels with no change in cGMP levels. 6. Methylene Blue (10 microM) partially inhibited EFS (10 Hz)‐evoked i‐NANC relaxation and cGMP accumulation, and almost completely inhibited both relaxation and cGMP accumulation evoked by SIN‐1 (1 mM). Methylene Blue had no significant effect on relaxation or cGMP accumulation evoked by SNP (100 microM). 7. Neural i‐NANC relaxations in HTSM are associated with a concurrent selective accumulation of cGMP which is unaffected by epithelium removal. This is inhibited in a stereoselective manner by L‐NAME and mimicked by SNP and SIN‐1; however, cGMP accumulation was greatly increased with SNP and SIN‐1 suggesting compartmentalized changes in cGMP content. VIP also caused relaxation associated with an increase of cAMP; however, no evidence was found for VIP being involved in i‐NANC relaxation. Hence nitric oxide (NO), or a NO‐containing complex, appears to mediate i‐NANC responses in human trachea in vitro.

[1]  J. Stamler,et al.  Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. , 1994, The Journal of pharmacology and experimental therapeutics.

[2]  Z. Katušić,et al.  Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnonimine. , 1994, The American journal of physiology.

[3]  M. Yacoub,et al.  Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. , 1993, The Journal of clinical investigation.

[4]  T. Bai,et al.  Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi. , 1993, The American journal of physiology.

[5]  I L Buxton,et al.  NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. , 1993, Circulation research.

[6]  J. Diamond,et al.  Role of cyclic GMP in airway smooth muscle relaxation. , 1993, Agents and actions. Supplements.

[7]  G. Verleden,et al.  Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. , 1992, Journal of applied physiology.

[8]  Richard Graham Knowles,et al.  Nitric oxide as a signal in blood vessels. , 1992, Trends in biochemical sciences.

[9]  L. Ignarro Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. , 1992, Biochemical Society transactions.

[10]  M. Rand,et al.  NITRERGIC TRANSMISSION: NITRIC OXIDE AS A MEDIATOR OF NON‐ADRENERGIC, NON‐CHOLINERGIC NEURO‐EFFECTOR TRANSMISSION , 1992, Clinical and experimental pharmacology & physiology.

[11]  M. Yacoub,et al.  Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. , 1992, European journal of pharmacology.

[12]  T. Torphy,et al.  Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators. , 1991, The Journal of pharmacology and experimental therapeutics.

[13]  A. Hobbs,et al.  Cyclic Nucleotide Content of the Rat Anococcygeus During Relaxations Induced by Drugs or by Non‐adrenergic, Non‐cholinergic Field Stimulation , 1991, The Journal of pharmacy and pharmacology.

[14]  M. Rand,et al.  Evidence that part of the NANC relaxant response of guinea‐pig trachea to electrical field stimulation is mediated by nitric oxide , 1991, British journal of pharmacology.

[15]  S. Moncada,et al.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo , 1990, British journal of pharmacology.

[16]  J. Nadel,et al.  Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi. , 1990, American journal of respiratory cell and molecular biology.

[17]  T. Torphy,et al.  Cyclic GMP: a potential mediator of neurally- and drug-induced relaxation of opossum lower esophageal sphincter. , 1989, The Journal of pharmacology and experimental therapeutics.

[18]  A. Gibson,et al.  N‐methylhydroxylamine inhibits and M&B 22948 potentiates relaxations of the mouse anococcygeus to non‐adrenergic, non‐cholinergic field stimulation and to nitrovasodilator drugs , 1989, British journal of pharmacology.

[19]  F. Murad,et al.  ANP relaxes bovine tracheal smooth muscle and increases cGMP. , 1989, The American journal of physiology.

[20]  J. Ellis,et al.  Effects of peptidases on non‐adrenergic, non‐cholinergic inhibitory responses of tracheal smooth muscle: a comparison with effects on VIP‐ and PHI‐induced relaxation , 1989, British journal of pharmacology.

[21]  M. Feelisch,et al.  On the Mechanism of NO Release from Sydnonimines , 1989, Journal of cardiovascular pharmacology.

[22]  W. Ko,et al.  Cyclic GMP affecting the tracheal nonadrenergic noncholinergic inhibitory system. , 1988, Respiration physiology.

[23]  J. Lammers,et al.  Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo. , 1988, Journal of applied physiology.

[24]  R. Gerzer,et al.  Cyclic GMP in cell function. , 1988, Advances in second messenger and phosphoprotein research.

[25]  F. Murad,et al.  Cyclic GMP synthesis and function. , 1987, Pharmacological reviews.

[26]  P. Barnes,et al.  Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries. , 1987, Blood vessels.

[27]  R. Furchgott,et al.  Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[28]  R. Busse,et al.  Stimulation of Soluble Guanylate Cyclase by an Acetylcholine‐Induced Endothelium‐Derived Factor from Rabbit and Canine Arteries , 1986, Circulation research.

[29]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[30]  A. H. Drummond,et al.  Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle , 1984, British journal of pharmacology.

[31]  R M Rapoport,et al.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[32]  L. Ignarro,et al.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.

[33]  G. Brooker,et al.  Radioimmunoassay of cyclic AMP and cyclic GMP. , 1979, Advances in cyclic nucleotide research.

[34]  S. Said,et al.  Vasoactive intestinal polypeptide promotes cyclic adenosine 3',5'-monophosphate accumulation in guinea-pig trachea. , 1978, British journal of pharmacology.

[35]  J. Beland,et al.  Nonadrenergic inhibitory nervous system in human airways. , 1976, Journal of applied physiology.

[36]  R. Butcher,et al.  Some Aspects of the Biological Role of Adenosine 3′,5′‐monophosphate (Cyclic AMP) , 1968 .